bpc-157 human clinical trial evidence review safety fda warning Big coming this July. Here's what athletes and patients should know about BPC-157, TB-500, and the broader peptide conversation. Always speak with your physician before starting any new protocol. #bpc157 # Patients Using Wellness Peptides Have
Description
Is the peptide being used for the same indication that was studied

Injection sites for extensor tendonitis should be placed subcutaneously on the dorsal (back) wrist surface, approximately 1-2 inches from the point of maximum tenderness

You do not fall off a cliff

The course of the treatment should be completed to ensure better efficacy of the medicine

Cycling off BPC157 after 46 weeks is recommended to mitigate unknown risks
